Initial prevalence of anal human papilloma virus infection in liver transplant recipients

Transplant International

Volumn 27, Issue 8, 2014, Pages 816-823

  Gra̧t, Michał ^a   Gra̧t, Karolina ^a   Hołõwko, Wacław ^a   Malejczyk, Magdalena ^a   Walter De Walthoffen, Szymon ^a   Lewandowski, Zbigniew ^a   Kobryń, Konrad ^a   Patkowski, Waldemar ^a   Majewski, Sławomir ^a   Młynarczyk, Grazyna ^a   Krawczyk, Marek ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

anal cancer; hepatitis B; human papilloma virus; liver transplantation; sexually transmitted disease; vaccination

Indexed keywords

ADULT; ALCOHOL LIVER DISEASE; ANUS CANCER; ARTICLE; FEMALE; GENOTYPE; GRAFT RECIPIENT; HEPATITIS B; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; LIVER TRANSPLANTATION; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEXUAL INTERCOURSE; SEXUALITY; ADVERSE EFFECTS; AGE; AGED; ANUS DISEASES; CLASSIFICATION; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SEXUAL BEHAVIOR;

ADULT; AGE FACTORS; AGED; ANUS DISEASES; FEMALE; GENOTYPE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SEXUAL BEHAVIOR;

EID: 84905013852     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12339     Document Type: Article

References (32)

1. Kaushic C, Roth KL, Anipindi V, Xiu F,. Increased prevalence of sexually transmitted viral infections in women: the role of female sex hormones in regulating susceptibility and immune responses. J Reprod Immunol 2011; 88: 204.
2. Franceschi S, Herrero R, Clifford GM, et al,. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006; 119: 2677.
3. Zandberg DP, Bhargava R, Badin S, Cullen KJ,. The role of human papillomavirus in nongenital cancers. CA Cancer J Clin 2013; 63: 57.
4. Steben M, Duarte-Franco E,. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol 2007; 107: S2.
5. van der Zee RP, Richel O, de Vries HJ, Prins JM,. The increasing incidence of anal cancer: can it be explained by trends in risk groups? Neth J Med 2013; 71: 401.
6. Olsen J, Jørgensen TR, Kofoed K, Larsen HK,. Incidence and cost of anal, penile, vaginal and vulvar cancer in Denmark. BMC Public Health 2012; 12: 1082.
7. Kurdgelashvili G, Dores GM, Srour SA, Chaturvedi AK, Huycke MM, Devesa SS,. Incidence of potentially human papillomavirus-related neoplasms in the United States, 1978 to 2007. Cancer 2013; 119: 2291.
8. Ouhoummane N, Steben M, Coutlée F, et al,. Squamous anal cancer: patient characteristics and HPV type distribution. Cancer Epidemiol 2013; 37: 807.
9. Daling JR, Madeleine MM, Johnson LG, et al,. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101: 270.
10. Engels EA, Pfeiffer RM, Fraumeni JF Jr, et al,. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011; 306: 1891.
11. Madeleine MM, Finch JL, Lynch CF, Goodman MT, Engels EA,. HPV-related cancers after solid organ transplantation in the United States. Am J Transplant 2013; 13: 3202.
12. Ronco G, Dillner J, Elfström KM, et al,. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 2013; 383: 524.
13. Bosch FX, Broker TR, Forman D, et al,. Comprehensive control of human papillomavirus infections and related diseases. Vaccine 2013; 31 (Suppl. 6): G1.
14. Lehtinen M, Paavonen J, Wheeler CM, et al,. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol 2012; 13: 89.
15. Roka S, Rasoul-Rockenschaub S, Roka J, Kirnbauer R, Mühlbacher F, Salat A,. Prevalence of anal HPV infection in solid-organ transplant patients prior to immunosuppression. Transpl Int 2004; 17: 366.
16. Patel HS, Silver AR, Levine T, Williams G, Northover JM,. Human papillomavirus infection and anal dysplasia in renal transplant recipients. Br J Surg 2010; 97: 1716.
17. Lu B, Viscidi RP, Lee JH, et al,. Human papillomavirus (HPV) 6, 11, 16, and 18 seroprevalence is associated with sexual practice and age: results from the multinational HPV Infection in Men Study (HIM Study). Cancer Epidemiol Biomarkers Prev 2011; 20: 990.
18. Tarallo PA, Smolowitz J, Carriero D, et al,. Prevalence of high-risk human papilloma virus among women with hepatitis C virus before liver transplantation. Transpl Infect Dis 2013; 15: 400.
19. Vriend HJ, Bogaards JA, van der Klis FR, et al,. Patterns of human papillomavirus DNA and antibody positivity in young males and females, suggesting a site-specific natural course of infection. PLoS One 2013; 8: e60696.
20. Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR,. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004; 101: 281.
21. Zieniewicz K, Grat M, Holowko W, et al,. Malignancies after liver transplantation-a single centre experience. Liver Transpl 2013; 19 (Suppl. 1): S281.
22. Nyitray AG, Carvalho da Silva RJ, Baggio ML, et al,. Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study. J Infect Dis 2011; 204: 1711.
23. Guimerà N, Lloveras B, Lindeman J, et al,. The occasional role of low-risk human papillomaviruses 6, 11, 42, 44, and 70 in anogenital carcinoma defined by laser capture microdissection/PCR methodology: results from a global study. Am J Surg Pathol 2013; 37: 1299.
24. Cornall AM, Roberts JM, Garland SM, Hillman RJ, Grulich AE, Tabrizi SN,. Anal and perianal squamous carcinomas and high-grade intraepithelial lesions exclusively associated with "low-risk" HPV genotypes 6 and 11. Int J Cancer 2013; 133: 2253.
25. Roset Bahmanyar E, Paavonen J, Naud P, et al,. Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial. Gynecol Oncol 2012; 127: 440.
26. Winer RL, Hughes JP, Feng Q, et al,. Prevalence and risk factors for oncogenic human papillomavirus infections in high-risk mid-adult women. Sex Transm Dis 2012; 39: 848.
27. Glick SN, Feng Q, Popov V, Koutsky LA, Golden MR,. High rates of incident and prevalent anal human papillomavirus infection among young men who have sex with men. J Infect Dis 2014; 209: 369.
28. Wiley DJ, Li X, Hsu H, et al,. Factors affecting the prevalence of strongly and weakly carcinogenic and lower-risk human papillomaviruses in anal specimens in a cohort of men who have sex with men (MSM). PLoS One 2013; 8: e79492.
29. Nyitray AG, Smith D, Villa L, et al,. Prevalence of and risk factors for anal human papillomavirus infection in men who have sex with women: a cross-national study. J Infect Dis 2010; 201: 1498.
30. Palefsky JM, Giuliano AR, Goldstone S, et al,. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011; 365: 1576.
31. Weis SE,. Current treatment options for management of anal intraepithelial neoplasia. Onco Targets Ther 2013; 6: 651.
32. de Pokomandy A, Rouleau D, Ghattas G, et al,. Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. J Infect Dis 2009; 199: 965.